Market Overview:
The global oxidative stress assays market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for antioxidant capacity assays, enzyme-based assays, and ROS-based assays. Pharmaceutical and biotechnology companies are the major end users of oxidative stress assay kits and services. The market in Asia Pacific is projected to grow at the highest CAGR during the forecast period owing to the growing demand for pharmaceuticals and biotechnology products in this region.
Product Definition:
Oxidative stress assays are used to measure the amount of oxidative stress in a sample. The importance of oxidative stress assays is that they can help to identify and measure the level of damage caused by oxidative stress. This information can then be used to help prevent or treat any negative effects that may result from this type of damage.
Indirect Assays:
Indirect assays are used for measuring the level of biomarkers in biological fluids such as serum, plasma, urine and CSF. The technique is based on the detection of a particular chemical reaction that takes place when a particular type of molecule is introduced into the fluid sample. Indirect assays are majorly used in medical diagnostics to detect diseases or conditions that have an underlying metabolic basis.
Antioxidant Capacity Assays:
Antioxidant capacity assays are used to measure the ability of a chemical compound or food substance to prevent or slow down the oxidation of other compounds. The most common antioxidants used in these types of tests are vitamin C, E, and carotenoids.
Application Insights:
The academic research institutes and clinical laboratories accounted for the largest revenue share in 2016. Oxidative stress plays a major role in the pathophysiology of several diseases, such as diabetes, cardiovascular disease, cancer and neurodegenerative disorders. Thus, increasing demand for biomarker-based diagnostic tests is expected to drive the market over the forecast period.
Moreover, pharmaceutical companies are also involved in R&D activities for developing novel therapeutics that can target oxidative stress mechanisms associated with various diseases. This has led to an increased number of products under development by these companies; however, limited penetration of these products due to high costs is anticipated to hamper market growth during the forecast period.
On other hand, product usage across different industries including food & beverage.
Regional Analysis:
North America Oxidative Stress Assays Market accounted for the largest share in 2016 owing to the presence of a large number of key players and well-established research infrastructure. In addition, high prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is expected to drive demand for oxidative stress tests in this region.
Asia Pacific market is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis among patients. Moreover, increasing investments by governments in healthcare facilities are also expected fuel regional growth during the forecast period.
Growth Factors:
- Increasing demand for personalized medicines
- Growing prevalence of chronic diseases
- Technological advancements in oxidative stress assay platforms
- Rising public and private investments in research and development of novel therapeutics
- Growing awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxidative Stress Assays Market Research Report
By Type
Indirect Assays, Antioxidant Capacity Assays, Enzyme-based Assays, Reactive Oxygen Species (ROS)-based Assays
By Application
Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations, Others
By Companies
Abcam plc (U.K.), AMS Biotechnology (U.K.), BioVision, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Enzo Biochem (U.S.), Merck and Co., Inc. (U.S.), Oxford Biomedical Research (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oxidative Stress Assays Market Report Segments:
The global Oxidative Stress Assays market is segmented on the basis of:
Types
Indirect Assays, Antioxidant Capacity Assays, Enzyme-based Assays, Reactive Oxygen Species (ROS)-based Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam plc (U.K.)
- AMS Biotechnology (U.K.)
- BioVision, Inc. (U.S.)
- Cell Biolabs, Inc. (U.S.)
- Enzo Biochem (U.S.)
- Merck and Co., Inc. (U.S.)
- Oxford Biomedical Research (U.S.)
- QIAGEN N.V. (Netherlands)
- Promega Corporation (U.S.)
- Sigma-Aldrich Corporation (U.S.)
- Thermo Fisher Scientific (U.S.)
Highlights of The Oxidative Stress Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Indirect Assays
- Antioxidant Capacity Assays
- Enzyme-based Assays
- Reactive Oxygen Species (ROS)-based Assays
- By Application:
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Clinical Laboratories
- Contract Research Organizations
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxidative Stress Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxidative stress assays are a type of laboratory test that measure the level of oxidative damage to cells or tissues. Oxidative stress can be caused by a number of factors, including exposure to environmental toxins and pollutants, age, genetics, and lifestyle choices. Oxidative damage can lead to cell death and inflammation, which can contribute to many chronic diseases.
Some of the major companies in the oxidative stress assays market are Abcam plc (U.K.), AMS Biotechnology (U.K.), BioVision, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Enzo Biochem (U.S.), Merck and Co., Inc. (U.S.), Oxford Biomedical Research (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific (U.S.).
The oxidative stress assays market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxidative Stress Assays Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxidative Stress Assays Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxidative Stress Assays Market - Supply Chain
4.5. Global Oxidative Stress Assays Market Forecast
4.5.1. Oxidative Stress Assays Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxidative Stress Assays Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxidative Stress Assays Market Absolute $ Opportunity
5. Global Oxidative Stress Assays Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxidative Stress Assays Market Size and Volume Forecast by Type
5.3.1. Indirect Assays
5.3.2. Antioxidant Capacity Assays
5.3.3. Enzyme-based Assays
5.3.4. Reactive Oxygen Species (ROS)-based Assays
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxidative Stress Assays Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxidative Stress Assays Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical and Biotechnology Companies
6.3.2. Academic Research Institutes
6.3.3. Clinical Laboratories
6.3.4. Contract Research Organizations
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxidative Stress Assays Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxidative Stress Assays Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxidative Stress Assays Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxidative Stress Assays Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxidative Stress Assays Demand Share Forecast, 2019-2026
9. North America Oxidative Stress Assays Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxidative Stress Assays Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxidative Stress Assays Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical and Biotechnology Companies
9.4.2. Academic Research Institutes
9.4.3. Clinical Laboratories
9.4.4. Contract Research Organizations
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxidative Stress Assays Market Size and Volume Forecast by Type
9.7.1. Indirect Assays
9.7.2. Antioxidant Capacity Assays
9.7.3. Enzyme-based Assays
9.7.4. Reactive Oxygen Species (ROS)-based Assays
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxidative Stress Assays Demand Share Forecast, 2019-2026
10. Latin America Oxidative Stress Assays Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxidative Stress Assays Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxidative Stress Assays Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academic Research Institutes
10.4.3. Clinical Laboratories
10.4.4. Contract Research Organizations
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxidative Stress Assays Market Size and Volume Forecast by Type
10.7.1. Indirect Assays
10.7.2. Antioxidant Capacity Assays
10.7.3. Enzyme-based Assays
10.7.4. Reactive Oxygen Species (ROS)-based Assays
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxidative Stress Assays Demand Share Forecast, 2019-2026
11. Europe Oxidative Stress Assays Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxidative Stress Assays Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxidative Stress Assays Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academic Research Institutes
11.4.3. Clinical Laboratories
11.4.4. Contract Research Organizations
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxidative Stress Assays Market Size and Volume Forecast by Type
11.7.1. Indirect Assays
11.7.2. Antioxidant Capacity Assays
11.7.3. Enzymebased Assays
11.7.4. Reactive Oxygen Species (ROS)-based Assays
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxidative Stress Assays Demand Share, 2019-2026
12. Asia Pacific Oxidative Stress Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxidative Stress Assays Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxidative Stress Assays Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academic Research Institutes
12.4.3. Clinical Laboratories
12.4.4. Contract Research Organizations
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxidative Stress Assays Market Size and Volume Forecast by Type
12.7.1. Indirect Assays
12.7.2. Antioxidant Capacity Assays
12.7.3. Enzyme-based Assays
12.7.4. Reactive Oxygen Species (ROS)-based Assays
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxidative Stress Assays Demand Share, 2019-2026
13. Middle East & Africa Oxidative Stress Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxidative Stress Assays Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxidative Stress Assays Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academic Research Institutes
13.4.3. Clinical Laboratories
13.4.4. Contract Research Organizations
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxidative Stress Assays Market Size and Volume Forecast by Type
13.7.1. Indirect Assays
13.7.2. Antioxidant Capacity Assays
13.7.3. Enzyme-based Assays
13.7.4. Reactive Oxygen Species (ROS)-based Assays
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxidative Stress Assays Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxidative Stress Assays Market: Market Share Analysis
14.2. Oxidative Stress Assays Distributors and Customers
14.3. Oxidative Stress Assays Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abcam plc (U.K.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AMS Biotechnology (U.K.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BioVision, Inc. (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cell Biolabs, Inc. (U.S.)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Enzo Biochem (U.S.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck and Co., Inc. (U.S.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Oxford Biomedical Research (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. QIAGEN N.V. (Netherlands)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Promega Corporation (U.S.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sigma-Aldrich Corporation (U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Thermo Fisher Scientific (U.S.)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
